Related Experiment Video
Updated: Apr 4, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Transcriptomic and Functional Pathway Analysis of Human Cervical Carcinoma Cancer Cells Response to Microtubule
Jin Wang1, Bin Yan2, Song-Mei Liu3
11. Scientific Research Center, Shanghai Public Health Clinical Center, 2901 Caolang Road, Jinshan District, Shanghai 201508, China ; 2. Department of Translational Molecular Pathology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Background:
There clearly is a need for effective chemotherapy for early-stage, high-risk patients with human cervical carcinoma. Vinblastine (VBL) is a key microtubule inhibitor, but unproven in its mechanisms as an important antitumor agent in cervical carcinoma.
Methods:
We selected the concentration of vinblastine inducing 30% cell death for analyses assessing the DNA content, gene expression and transcriptional gene regulation of VBL-treated KB-3 cells.
Results:
Transcriptomic and hierarchical clustering analysis demonstrated that treatment of KB-3 cells with VBL altered the expression of a diverse group of genes with G2/M arrest, which regulated by four oncogenic or tumor suppresser transcription factors (AP1, NFKB1, RELA, and TP53). Functional pathway analysis revealed the disease response to the biological effects of vinblastine in cervical carcinoma chemotherapy including protein ubiquitination pathway, RhoGDI signaling, integrin signaling, agranulocyte adhesion and biapedesis, and actin nucleation pathways. Northern blots also confirmed that KRT-7, FN14, IER3, and ID1 were deregulated in VBL-treated KB-3 cells.
Conclusion:
Transcriptional time series profiles and a functional pathway analysis of VBL-treated KB-3 cells will provide a new strategy for improving microtubule inhibitor chemotherapy for cervical carcinoma.
Insights
Vinblastine (VBL) chemotherapy in cervical carcinoma cells induced G2/M arrest and altered gene expression. This study reveals VBL
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Effective chemotherapy is needed for early-stage, high-risk cervical carcinoma.
- Vinblastine (VBL) is a microtubule inhibitor with unproven mechanisms in cervical cancer.
Purpose of the Study:
- To investigate the molecular mechanisms of Vinblastine (VBL) in cervical carcinoma cells.
- To identify potential therapeutic targets for VBL-based chemotherapy.
Main Methods:
- KB-3 cervical carcinoma cells were treated with VBL at a concentration inducing 30% cell death.
- Analyses included DNA content, gene expression, and transcriptional gene regulation.
- Transcriptomic and functional pathway analyses were performed.
Main Results:
- VBL treatment induced G2/M cell cycle arrest in KB-3 cells.
- Gene expression was altered, regulated by transcription factors AP1, NFKB1, RELA, and TP53.
- Key pathways affected include protein ubiquitination, RhoGDI signaling, and integrin signaling.
Conclusions:
- VBL alters gene expression and cell cycle progression in cervical carcinoma cells.
- Understanding these transcriptional changes offers a new strategy for VBL chemotherapy.
- Identified pathways and regulated genes may serve as therapeutic targets.
Related Concept Videos
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Destabilization of Microtubules
Microtubules in Cell Motility

